Hologic CEO on Q4 earnings beat, $2.7 billion cash on balance sheet

Steve MacMillan, Hologic CEO, joins 'Squawk on the Street' to discuss key tailwinds Hologic is seeing, strategic use cases for the company's cash, and playbooks for weight-loss drugs.